Aarti Drugs stock | Price target for 2026, price & analyst rating

Aarti Drugs

BSE:524348

Rp 330,60

Rp-10,15 (-2,98%)

330,60 Rp

Rp-10,15 (-2,98%)

End-of-day quote: 03/27/2026

Aarti Drugs Stock Value

The analyst rating for BSE:524348 is currently Outperform.

Outperform

Aarti Drugs Company Info

EPS Growth 5Y

4,42%

Market Cap

Rp30,17 B

Long-Term Debt

Rp2,75 B

Annual earnings

04/30/2026 (E)

Dividend

Rp1,95

Dividend Yield

0,59%

Founded

1984

Industry

Health Care

Country

India

Website

Aarti Drugs

ISIN Number

INE767A01016

Website

http://www.aartidrugs.co.in

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp480,00

45.19%

Last Update: 03/28/2026

Analysts: 1

Highest Price Target Rp480,00

Average Price Target Rp480,00

Lowest Price Target Rp480,00

In the last five quarters, Aarti Drugs’s Price Target has fallen from Rp519,26 to Rp465,00 - a -10,45% decrease. One analysts predict that Aarti Drugs’s share price will increase in the coming year, reaching Rp480,00. This would represent an increase of 45,19%.

Top growth stocks in the health care sector (5Y.)

What does Aarti Drugs do?

Aarti Drugs Limited focuses on the manufacture and marketing of pharmaceutical and chemical products. Business Segments The company is structured around several business segments that cater to diverse market needs. The pharmaceutical segment forms a significant part of the company's operations, encompassing the production of active pharmaceutical ingredients (APIs) and finished formulations. This segment focuses on a wide variety of therapeutic categories, including analgesics, antihypertensi...

Aarti Drugs Limited focuses on the manufacture and marketing of pharmaceutical and chemical products.

Business Segments

The company is structured around several business segments that cater to diverse market needs.

The pharmaceutical segment forms a significant part of the company's operations, encompassing the production of active pharmaceutical ingredients (APIs) and finished formulations. This segment focuses on a wide variety of therapeutic categories, including analgesics, antihypertensive, and anti-diabetics, meeting both domestic and international demands.

The specialty chemicals segment comprises manufacturing intermediates and specialty chemicals used across various industries, including agrochemicals and personal care.

In addition to this, the company has ventured into contract manufacturing, allowing it to expand its capabilities and offer tailored solutions to pharmaceutical companies seeking high-quality production services.

Business Strategy

The company employs a multi-faceted business strategy aimed at maintaining a competitive edge in the pharmaceutical and specialty chemicals markets. The company emphasizes research and development as a cornerstone of its strategy, focusing on innovation and improvements in product quality and efficacy.

Partnerships play a crucial role in the company's strategy. Collaborating with various stakeholders, including research institutions and technology providers allows the company to leverage outside expertise and accelerate its product development timelines.

Products and Services

The company offers a comprehensive range of products and services within the pharmaceutical and specialty chemicals sectors.

The company's pharmaceutical portfolio includes APIs, which are crucial for the manufacturing of medications utilized in various therapeutic categories like pain management, cardiology, and diabetes management.

The company also provides finished formulations, ensuring that its products are ready for end-users. This segment features a diverse array of dosage forms, including tablets, capsules, and syrups, designed to enhance patient adherence and therapeutic outcomes.

In the specialty chemicals division, the company manufactures a wide range of chemicals used across multiple industries, including agriculture and personal care. This includes intermediates and additives.

Contract manufacturing services enables the company to assist other pharmaceutical companies in producing their products. This service is tailored to meet specific client requirements, thereby enhancing operational flexibility and business partnerships.

The company also offers consulting services in areas like regulatory compliance and quality management, providing clients with expertise and support to navigate the complex pharmaceutical landscape.

Geographical Markets Served

The company serves a global market, with a robust presence in domestic territories and various international regions. The company is strategically positioned to cater to clients across North America, Europe, Asia, and other emerging markets, ensuring comprehensive service delivery irrespective of geographical boundaries.

Seasonality

The company experiences seasonality based on market demands and industry trends. While pharmaceutical sales may exhibit some seasonal influence, particularly with products linked to chronic disease management. The specialty chemicals segment may face cyclical trends based on global market conditions.

Customers

The company serves a diverse clientele across various sectors, reflecting its extensive product offerings. The company's customer base includes pharmaceutical manufacturers, healthcare providers, distributors, and retailers.

The company has developed relationships with prominent pharmaceutical companies and healthcare institutions, both domestically and internationally.

Sales and Marketing

The company employs a multi-channel approach to sales and marketing, utilizing both traditional and digital platforms to reach diverse audiences effectively. The company's marketing strategies incorporate direct sales, partnerships with distributors, and online platforms to promote its products and services.

History

Aarti Drugs Limited was founded in 1984. The company was incorporated in 1984.

New support ticket

Explore

Aarti Drugs Stock Value

Aarti Drugs Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Aarti Drugs do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Aarti Drugs Stock Value

Aarti Drugs Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Aarti Drugs do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.